John P. Iwanicki weighs in on the recent dispute over the patent application for TIC10, an anticancer agent set to enter human clinical trials, in “Tug of War Over Promising Cancer Drug Candidate,” in Chemical & Engineering News.
Please click here to read the article.
Posted: May 21, 2014
